Document is current

Article History

Received: 12 December 2024

Accepted: 30 March 2026

First Online: 10 April 2026

Declarations

:

: Not applicable.

: Not applicable.

: GM and RaS received funding from Promotion Santé Suisse (Gesundheitsförderung Schweiz) under contract no. 18.191/ K50001, from the Health Departement Basel-City, in the context of a Horizon Europe project from the Swiss State Secretariat for Education, Research and lnnovation (SERI) under contract number 22.00094, and from Wings Healths in the context of a proof-of-concept study. GM received funding from the Swiss Heart Foundation under project no. FF21101, from the Research Foundation of the International Psychoanalytic University (IPU) Berlin under projects no. 5087 and 5217, from the Swiss National Science Foundation (SNSF) under project no. 100014_135328, from the German Federal Ministry of Education and Research under budget item 68606, from the Hasler Foundation under project No. 23004, and from Wings Health in the context of a proof-of-concept study. GM is a co-founder and shareholder of Therayou AG, active in digital and blended mental healthcare. GM receives royalties from publishing companies as author, including a book published by Springer, and an honorarium from Lundbeck for speaking at a symposium. Furthermore, GM is compensated for providing psychotherapy to patients, acting as a supervisor, serving as a self-experience facilitator (‘Selbsterfahrungsleiter’), and for postgraduate training of psychotherapists and supervisors.RaS received a speaker honorarium from Novartis. RS is coeditor of the German AWMF S3-Guidelines on Functional Complaints, and contributed to the German guidelines on irritable bowel syndrome, and on Lyme Borreliosis. RS is chairman of the Basel Institute for Psychosomatic Medicine (BIPM) and founder and managing director of the Psychosomatic and Psychosocial Services GmbH, that develops and implements psychosomatic and psychosocial training and continuing education programs. RS is member of the Swiss Academy of Psychosomatic and Psychosocial Medicine (SAPPM) – where he is member of the Scientific Advisory Board, of the Société Médicale Suisse d’Hypnose (SMSH), of the Dt. Kollegium für Psychosomatische Medizin (DKPM), of the Dt. Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM), and of the German Balint Society (DBG). RS serves as spokesman of DKPM and DGPM for Consultation and Liaison Psychosomatics. He is member of the board of trustees of the Foundation Psychosomatic and Social Medicine (Ascona Foundation). All other authors declare no conflict of interest.